ALDH1A1 and triple-negative breast carcinoma: Pretreatment with a sulforaphane compound had in vivo tumor inhibitory effects, which were mediated through reduced Cripto and other stem cell markers, ALDH1A1, Nanog, and homologue CRIPTO-3 expression in triple negative breast cancer [100].